We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
AUM
$252M
AUM Growth
+$17.5M
Cap. Flow
+$8.01M
Cap. Flow %
3.18%
Top 10 Hldgs %
53.98%
Holding
71
New
4
Increased
41
Reduced
10
Closed
4
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
51
CVS Health
CVS
$137B
$237K 0.09%
2,827
-140
-5% -$11.5K
NEM icon
52
Newmont
NEM
$95.8B
$235K 0.09%
3,700
REGN icon
53
Regeneron Pharmaceuticals
REGN
$70.9B
$235K 0.09%
422
-83
-16% -$42K
AGI icon
54
Alamos Gold
AGI
$11.9B
$218K 0.09%
28,500
ESGD icon
55
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
$216K 0.09%
2,721
+34
+1% +$2.71K
B
56
Barrick Mining
B
$58.5B
$207K 0.08%
10,000
HSIC icon
57
Henry Schein
HSIC
$10B
$206K 0.08%
2,808
-327
-10% -$24.6K
AEM icon
58
Agnico Eagle Mines
AEM
$68.5B
$203K 0.08%
+3,350
New +$224K
KGC icon
59
Kinross Gold
KGC
$27B
$203K 0.08%
32,000
DYAI icon
60
Dyadic International
DYAI
$45.9M
$112K 0.04%
31,246
+2,036
+7% +$8.53K
GERN icon
61
Geron
GERN
$924M
$108K 0.04%
76,486
+5,588
+8% +$8.13K
VRNA
62
DELISTED
Verona Pharma
VRNA
$104K 0.04%
15,506
+1,404
+10% +$9.73K
EIGR
63
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$82K 0.03%
334
-25
-7% -$6.24K
ORTX
64
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$75K 0.03%
1,729
+118
+7% +$6.57K
SPY icon
65
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$51K 0.02%
+5,000
New +$2.09M
ADAM
66
Adamas Trust
ADAM
$807M
$45K 0.02%
2,500
PEI
67
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$25K 0.01%
667
BSV icon
68
Vanguard Short-Term Bond ETF
BSV
$44.7B
-36,470
Closed -$3M
DVAX
69
DELISTED
Dynavax Technologies
DVAX
-12,290
Closed -$121K
RVLP
70
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
-30,118
Closed -$99K
ATNX
71
DELISTED
Athenex, Inc. Common Stock
ATNX
-765
Closed -$65K

Similar funds

Forefront Analytics's Q2 2021 Portfolio in Review

As of Q2 2021, Forefront Analytics held 71 positions worth $252M, up 7.5% from $235M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Forefront Analytics deployed $8.01M of net new capital in Q2 2021, opening 4 new positions and adding to 41 existing holdings. Its largest new stake was Invesco Solar ETF: 43,277 shares worth $3.87M.

By sector, the portfolio is most concentrated in Financials at 0.87% of assets, up from 0.86% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was iShares 3-7 Year Treasury Bond ETF, an estimated $551K trimmed.

  • Forefront Analytics's largest Q2 2021 buy was Invesco Solar ETF: 43,277 shares worth $3.87M.
  • Forefront Analytics added most to PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q2 2021, an estimated $1.06M increase.
  • Forefront Analytics's biggest Q2 2021 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $551K.
  • Forefront Analytics fully exited Vanguard Short-Term Bond ETF in Q2 2021, selling an estimated $3M.
  • Forefront Analytics's ten largest holdings make up 54% of its $252M portfolio in Q2 2021.
  • Forefront Analytics opened 4 new positions and closed 4 in Q2 2021.
  • Forefront Analytics's portfolio value rose 7.5% quarter-over-quarter to $252M.

Based on Forefront Analytics's 13F filing for Q2 2021, filed 10 Aug 2021.